首页 › 股票 › PHVS

PHVS — PHARVARIS N V

申报持仓市值$2.45B
持有基金数(最新)174
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)131
机构持仓市值$2.46B · 71.43M 股
新建/增持/减仓/清仓25 / 47 / 34 / 10 · 更新于 2026-11-14
前五大/前十大集中度36.9% / 58.7%
机构整体持仓变动 增持 +6.5% (+4.20M 股)
机构持仓市值变动 上升 +30.6%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 131 家机构在其最新 13F 申报中持有 PHVS(PHARVARIS N V),合计申报市值 $2.46B,对应 71.43M 股。按股数计算较上季度增持 6.5%(+4.20M 股),申报市值环比上升 30.6%。持仓集中度较高:前五大持有人占申报市值的 36.9%,前十大的集中度为 58.7%。

与上一季度相比,25 家新建仓位、47 家加仓、34 家减仓、10 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

PHARVARIS N V(PHVS)的主要机构持有人包括 Fidelity Management & Research (FMR)、Foresite Capital Management IV, LLC、venBio Partners LLC,按 13F 申报市值在本页 174 家持有人中排名居前。

PHVS 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

持有 PHVS 的传奇投资人

我们追踪的超级投资人在各自最新 13F 申报中持有 PHVS 的名单——每位投资人按其自身最近一个季度展示。

投资人 季度 股数 金额 组合权重 变化
维京全球 Q2 2026 3.65M $126.33M 0.37% 持有

这些投资人共同持有哪些股票?→  ·  嵌入此组件 →

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 64 17.97M $569.97M -13.0%
Q2 2026 131 71.43M $2.46B +6.5%
Q1 2026 116 65.65M $1.84B -1.1%
Q4 2025 112 65.99M $1.80B +4.2%
Q3 2025 86 64.17M $1.58B +7.9%
Q2 2025 61 49.47M $857.21M -1.8%
Q1 2025 54 49.18M $762.88M +0.5%
Q4 2024 57 48.76M $926.15M +1.4%

表内 8 个季度中,机构持股合计减少 63%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+7.9%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 6.92M $219.56M 0.01% 增持
EQT Fund Management S.a r.l. 历史持仓 3.42M $108.63M 11.46% 持有
GENERAL ATLANTIC, L.P. 历史持仓 1.65M $52.39M 2.15% 减持
Jones Hill Capital LP 历史持仓 987.64K $31.33M 5.32% 增持
BlackRock Inc 966.72K $30.66M 0.00% 增持
Patient Square Capital LP 历史持仓 808.64K $25.65M 4.09% 增持
Morgan Stanley 412.83K $13.09M 0.00% 增持
BNP Paribas Asset Management Holding S.A. 409.52K $12.99M 0.01% 增持
NEXTBio Capital Management LP 历史持仓 372.55K $11.82M 5.14% 增持
UBS Group AG 349.07K $11.07M 0.01% 增持
Qube Research & Technologies Ltd 282.87K $8.97M 0.02% 增持
Walleye Capital LLC 187.57K $5.95M 0.03% 减持
STATE STREET CORP 151.41K $4.80M 0.00% 减持
Nantahala Capital Management, LLC 150.00K $4.76M 0.22% 新进
HighVista Strategies LLC 历史持仓 126.17K $4.00M 1.05% 减持
Geode Capital Management 89.26K $2.83M 0.00% 减持
TD ASSET MANAGEMENT INC 71.23K $2.26M 0.00% 增持
Deutsche Bank AG 61.12K $1.94M 0.00% 增持
Swiss National Bank 49.46K $1.57M 0.00% 增持
Jump Financial, LLC 44.10K $1.40M 0.01% 新进
Amundi US 43.13K $1.37M 0.00% 减持
JPMorgan Chase & Co 41.52K $1.32M 0.00% 增持
Manulife Financial 40.30K $1.28M 0.00% 增持
Squarepoint Ops LLC 38.13K $1.21M 0.01% 减持
Birchview Capital, LP 历史持仓 29.85K $946.75K 0.56% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Fidelity Management & Research (FMR) 6.57M $227.03M 0.01% 增持
GENERAL ATLANTIC, L.P. 历史持仓 6.55M $226.53M 7.79% 减持
Foresite Capital Management IV, LLC 历史持仓 4.78M $165.24M 56.95% 持有
venBio Partners LLC 历史持仓 4.64M $160.57M 30.92% 持有
Viking Global Investors 3.65M $126.33M 0.37% 持有
VIKING GLOBAL INVESTORS LP 3.65M $126.33M 0.36% 持有
EQT Fund Management S.a r.l. 历史持仓 3.42M $118.42M 13.73% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 3.38M $116.74M 1.46% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 2.68M $92.52M 5.50% 持有
Wellington Management Group 2.39M $82.75M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 2.39M $82.75M 0.02% 增持
Polar Capital Holdings Plc 2.33M $80.45M 0.23% 增持
Point72 Asset Management 1.64M $56.75M 0.22% 增持
Commodore Capital LP 历史持仓 1.43M $49.28M 2.94% 减持
Novo Holdings A/S 历史持仓 1.40M $48.41M 2.81% 减持
Saturn V Capital Management LP 历史持仓 1.31M $45.44M 6.51% 增持
TCG Crossover Management, LLC 历史持仓 1.01M $34.86M 0.84% 新进
Sofinnova Investments, Inc. 历史持仓 881.30K $30.48M 1.62% 增持
5AM Venture Management, LLC 历史持仓 797.60K $27.58M 9.58% 持有
Seven Fleet Capital Management LP 历史持仓 774.50K $26.78M 4.42% 增持
BlackRock Inc 771.45K $26.68M 0.00% 增持
Cormorant Asset Management, LP 历史持仓 750.00K $25.93M 1.33% 减持
Soleus Capital Management, L.P. 历史持仓 730.91K $25.27M 0.87% 增持
Jones Hill Capital LP 历史持仓 677.88K $23.44M 4.98% 增持
Patient Square Capital LP 历史持仓 671.21K $23.21M 3.60% 增持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
GENERAL ATLANTIC, L.P. 历史持仓 8.03M $226.88M 10.56% 持有
Fidelity Management & Research (FMR) 6.28M $177.54M 0.01% 减持
Foresite Capital Management IV, LLC 历史持仓 4.78M $134.99M 56.94% 持有
venBio Partners LLC 历史持仓 4.64M $131.06M 46.72% 持有
Viking Global Investors 3.65M $103.21M 0.29% 持有
VIKING GLOBAL INVESTORS LP 3.65M $103.21M 0.29% 持有
EQT Fund Management S.a r.l. 历史持仓 3.42M $96.75M 9.48% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 3.13M $88.31M 1.16% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 2.68M $75.58M 6.82% 减持
Wellington Management Group 2.12M $59.86M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 2.12M $59.86M 0.01% 增持
Commodore Capital LP 历史持仓 1.92M $54.21M 3.14% 增持
Novo Holdings A/S 历史持仓 1.75M $49.44M 4.01% 持有
Saturn V Capital Management LP 历史持仓 1.20M $33.94M 6.15% 增持
Point72 Asset Management 1.01M $28.45M 0.11% 增持
Cormorant Asset Management, LP 历史持仓 1.00M $28.25M 1.46% 减持
Sofinnova Investments, Inc. 历史持仓 818.33K $23.12M 0.97% 增持
5AM Venture Management, LLC 历史持仓 797.60K $22.53M 6.25% 持有
Polar Capital Holdings Plc 781.02K $22.06M 0.10% 增持
BlackRock Inc 757.21K $21.39M 0.00% 增持
Soleus Capital Management, L.P. 历史持仓 702.05K $19.83M 0.80% 持有
Rock Springs Capital Management LP 历史持仓 645.53K $18.24M 1.07% 增持
Kynam Capital Management, LP 历史持仓 640.39K $18.09M 1.17% 持有
Patient Square Capital LP 历史持仓 493.00K $13.93M 2.47% 减持
Ikarian Capital, LLC 历史持仓 486.86K $13.75M 1.68% 持有

Q4 2025 — 25 家基金

基金股数金额组合权重变化
GENERAL ATLANTIC, L.P. 历史持仓 8.03M $222.87M 7.76% 持有
Fidelity Management & Research (FMR) 6.40M $177.58M 0.01% 持有
Foresite Capital Management IV, LLC 历史持仓 4.78M $132.61M 57.73% 持有
venBio Partners LLC 历史持仓 4.64M $128.74M 59.53% 持有
Viking Global Investors 3.65M $101.38M 0.27% 持有
VIKING GLOBAL INVESTORS LP 3.65M $101.38M 0.27% 持有
EQT Fund Management S.a r.l. 历史持仓 3.42M $95.03M 8.55% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 3.13M $86.75M 1.22% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 2.80M $77.76M 5.96% 减持
Wellington Management Group 1.91M $52.89M 0.01% 增持
WELLINGTON MANAGEMENT GROUP LLP 1.91M $52.89M 0.01% 增持
Commodore Capital LP 历史持仓 1.89M $52.43M 3.49% 减持
Novo Holdings A/S 历史持仓 1.75M $48.56M 3.77% 持有
Saturn V Capital Management LP 历史持仓 1.14M $31.64M 5.81% 增持
Cormorant Asset Management, LP 历史持仓 1.08M $30.05M 1.39% 减持
PRICE T ROWE ASSOCIATES INC /MD/ 941.61K $26.13M 0.00% 增持
5AM Venture Management, LLC 历史持仓 797.60K $22.13M 6.96% 持有
Sofinnova Investments, Inc. 历史持仓 745.17K $20.68M 0.89% 增持
Point72 Asset Management 711.62K $19.75M 0.07% 增持
BlackRock Inc 708.56K $19.66M 0.00% 增持
Soleus Capital Management, L.P. 历史持仓 702.05K $19.48M 0.72% 增持
Octagon Capital Advisors LP 历史持仓 671.47K $18.63M 2.26% 减持
Kynam Capital Management, LP 历史持仓 640.39K $17.77M 1.19% 减持
Rock Springs Capital Management LP 历史持仓 623.40K $17.30M 0.90% 持有
Patient Square Capital LP 历史持仓 542.70K $15.06M 3.22% 增持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
GENERAL ATLANTIC, L.P. 历史持仓 8.03M $200.38M 6.02% 增持
Fidelity Management & Research (FMR) 6.40M $159.66M 0.01% 增持
Foresite Capital Management IV, LLC 历史持仓 4.78M $119.23M 65.29% 增持
venBio Partners LLC 历史持仓 4.64M $115.75M 65.62% 增持
VIKING GLOBAL INVESTORS LP 3.65M $91.15M 0.24% 持有
Viking Global Investors 3.65M $91.15M 0.24% 持有
EQT Fund Management S.a r.l. 历史持仓 3.42M $85.44M 4.59% 新进
Bain Capital Life Sciences Investors, LLC 历史持仓 3.18M $79.37M 5.27% 减持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 2.44M $60.94M 0.98% 增持
Commodore Capital LP 历史持仓 2.42M $60.34M 2.95% 增持
Paradigm Biocapital Advisors LP 1.84M $45.80M 1.53% 增持
Novo Holdings A/S 历史持仓 1.75M $43.66M 2.81% 增持
WELLINGTON MANAGEMENT GROUP LLP 1.73M $43.28M 0.01% 新进
Wellington Management Group 1.73M $43.28M 0.01% 新进
Cormorant Asset Management, LP 历史持仓 1.36M $34.01M 2.35% 减持
Saturn V Capital Management LP 历史持仓 886.33K $22.11M 4.85% 新进
PRICE T ROWE ASSOCIATES INC /MD/ 816.81K $20.38M 0.00% 增持
5AM Venture Management, LLC 历史持仓 797.60K $19.90M 7.29% 持有
Sofinnova Investments, Inc. 历史持仓 739.88K $18.46M 1.08% 增持
Octagon Capital Advisors LP 历史持仓 722.60K $18.03M 2.81% 增持
Kynam Capital Management, LP 历史持仓 675.00K $16.84M 1.25% 新进
Venrock Adviser, LLC 674.60K $16.83M 0.95% 减持
Soleus Capital Management, L.P. 历史持仓 647.05K $16.14M 0.81% 减持
Balyasny Asset Management 625.76K $15.61M 0.05% 新进
Rock Springs Capital Management LP 历史持仓 623.40K $15.55M 0.92% 持有

Q2 2025 — 25 家基金

基金股数金额组合权重变化
GENERAL ATLANTIC, L.P. 历史持仓 7.53M $132.55M 3.65% 持有
Fidelity Management & Research (FMR) 5.42M $95.43M 0.01% 增持
Foresite Capital Management IV, LLC 历史持仓 4.41M $77.63M 62.70% 持有
venBio Partners LLC 历史持仓 4.29M $75.49M 65.78% 持有
VIKING GLOBAL INVESTORS LP 3.65M $64.30M 0.19% 持有
Viking Global Investors 3.65M $64.30M 0.19% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 3.30M $58.14M 7.27% 持有
Venrock Adviser, LLC 2.05M $36.04M 2.70% 减持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 2.02M $35.51M 0.69% 持有
Commodore Capital LP 历史持仓 1.91M $33.64M 2.38% 持有
Novo Holdings A/S 历史持仓 1.73M $30.36M 2.14% 持有
Cormorant Asset Management, LP 历史持仓 1.45M $25.60M 1.91% 减持
Paradigm Biocapital Advisors LP 1.06M $18.71M 0.80% 新进
5AM Venture Management, LLC 历史持仓 797.60K $14.04M 5.40% 持有
PRICE T ROWE ASSOCIATES INC /MD/ 767.32K $13.51M 0.00% 增持
Soleus Capital Management, L.P. 历史持仓 732.97K $12.90M 0.85% 减持
Octagon Capital Advisors LP 历史持仓 672.60K $11.84M 2.60% 减持
Rock Springs Capital Management LP 历史持仓 623.40K $10.97M 0.69% 持有
Sofinnova Investments, Inc. 历史持仓 585.53K $10.31M 0.68% 减持
SPHERA FUNDS MANAGEMENT LTD. 309.93K $5.45M 1.38% 减持
Patient Square Capital LP 历史持仓 244.28K $4.30M 1.55% 持有
Rosalind Advisors, Inc. 223.63K $3.94M 2.14% 持有
BlackRock Inc 201.09K $3.54M 0.00% 增持
Tetragon Partners GP Ltd 历史持仓 188.10K $3.31M 0.60% 增持
TD ASSET MANAGEMENT INC 99.51K $1.75M 0.00% 增持

查看全部 174 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Fidelity Management & Research (FMR) 6.92M 6.57M 6.28M 6.40M 6.40M 5.42M 5.40M 5.40M 5.21M 5.21M 5.19M 5.19M 3.21M 3.39M 3.32M 3.32M 3.32M 3.32M 3.32M 3.30M
EQT Fund Management S.a r.l. 3.42M 3.42M 3.42M 3.42M 3.42M — — — — — — — — — — — — — — —
GENERAL ATLANTIC, L.P. 1.65M 6.55M 8.03M 8.03M 8.03M 7.53M 7.53M 7.53M 7.53M 7.53M 7.53M 6.16M 4.41M — — — — — — —
Jones Hill Capital LP 987.64K 677.88K 167.01K — — — — — — — — — — — — — — — — —
BlackRock Inc 966.72K 771.45K 757.21K 708.56K 414.42K 201.09K 192.87K 194.19K 195.35K — — — — — — — — — — —
Patient Square Capital LP 808.64K 671.21K 493.00K 542.70K 345.38K 244.28K 245.50K 207.60K 242.34K — — — — — — — — — — —
Morgan Stanley 412.83K 97.34K 164.32K 248.33K 58.26K 59.77K 75.36K 27.00K 24.25K 23.30K 29.04K 22.49K 33.70K 45.33K 48.98K 38.18K 19.09K 16.82K 16.18K 18.26K
BNP Paribas Asset Management Holding S.A. 409.52K 4.56K 5.72K 5.51K 3.26K 3.26K — — — — — — — — — — — — — —
NEXTBio Capital Management LP 372.55K 108.06K — — — — — — — — — — — — — — — — — —
UBS Group AG 349.07K 254.79K 71.94K 137.73K 130.75K 3.74K 7.45K 1.04K 1.59K 167 — — 50 1.30K 422 2.80K — 799 728 423
Qube Research & Technologies Ltd 282.87K 139.85K 71.21K 14.71K — — — — — — 30.14K 32.32K 2.58K — — — — — — —
Walleye Capital LLC 187.57K 200.42K — — — — — — — 48.77K 97.18K 77.87K 81.02K — — — — — — —
STATE STREET CORP 151.41K — 152.94K 161.50K 142.78K 93.67K 93.78K 92.01K 53.98K — — — — — — — — — — —
Nantahala Capital Management, LLC 150.00K — — — — — — — — — — — — — — — — — — —
HighVista Strategies LLC 126.17K 160.49K 97.87K 162.37K — 23.74K 22.77K 22.77K 22.77K 16.75K 16.75K — — — — — — — — —
Geode Capital Management 89.26K 89.91K 89.13K 86.80K 78.54K 54.10K 38.33K 38.33K 36.98K 31.22K 31.22K 21.59K 21.59K 18.64K 18.64K 18.64K 18.64K 18.64K 18.64K 18.64K
TD ASSET MANAGEMENT INC 71.23K 38.46K 54.83K 120.25K 104.36K 99.51K 78.12K 55.22K 36.22K 85.82K 112.62K — — — — — — — — —
Deutsche Bank AG 61.12K 53.47K 53.72K 56.39K 51.80K 28.19K 28.17K 18.17K 16.08K — — — — — — — — — — —
Swiss National Bank 49.46K 39.36K 44.76K 44.76K 42.36K 26.26K 26.26K 26.26K 26.26K — — — — — — — — — — —
Jump Financial, LLC 44.10K — 19.50K 26.30K — — — — — — 11.70K — — — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold PHVS?

As of 2026-Q2, 131 institutional funds reported holding PHVS (PHARVARIS N V) in SEC 13F filings, with a combined reported value of $2.46B.

How many shares of PHVS do institutions own?

13F filers reported 71.43M shares of PHVS, worth $2.46B in aggregate at the end of 2026-Q2.

Is institutional ownership of PHVS rising or falling?

Share counts moved +6.5% versus the prior quarter — accumulation.

Who are the top institutional holders of PHVS?

The largest 13F holders are Fidelity Management & Research (FMR), Foresite Capital Management IV, LLC, venBio Partners LLC, Viking Global Investors, VIKING GLOBAL INVESTORS LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of PHARVARIS N V?

The major shareholders of PHARVARIS N V (PHVS) by reported 13F value are Fidelity Management & Research (FMR), Foresite Capital Management IV, LLC, venBio Partners LLC, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 174 institutional holders.

Which legendary investors own PHVS?

1 of the legendary investors tracked on HoldingsHub report PHVS (PHARVARIS N V) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on PHVS?

1 tracked superinvestors hold PHVS simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 PHVS」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/PHVS/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →